HCPLive

Neurology - Page 14

Latest Headlines

Q&A With Mark Freedman, MD, of Ottawa Hospital: Developing Medication for Multiple Sclerosis a Long and Complicated Process
Medications in general can take a long time to develop. Depending on the condition they treat that process can be even longer as more questions have to be answered before they can be introduced to the field. This is particularly true of multiple sclerosis treatments.
Q&A With Mark Freedman, MD, of Ottawa Hospital: Study Results show Benefits of Teriflunomide in Multiple Sclerosis Treatment
As a treatment for multiple sclerosis teriflunomide has shown benefits over a long development period and has proven effective in the treatment of patients with the relapsing-remitting form of the condition.
Q&A With Alasdair Coles of Cambridge Neurology: Alemtuzumab As Aggressive Multiple Sclerosis Treatment
For as many drugs and therapies as there are for multiple sclerosis some are more aggressive than others. Alemtuzumab's approach is more on the aggressive end of the spectrum.
Poor Quality of Sleep Associated with Increased Pain Severity
Genetic mutations are not solely to blame for increased neuropathic pain and the way pain is processed in the brain. Norwegian researchers identified a link between a person’s quality of sleep and pain sensitivity.
Mindfulness-Based Therapy Prevents Depression Relapse
The first large study to compare mindfulness-based cognitive therapy (MBCT)—a psychological therapy designed to change the way people think and feel about their experiences—with maintenance antidepressant medication suggests that MBCT could offer an alternative to antidepressants for preventing depression relapse.

Most Popular in Neurology - Page 14

Recent Published Journal

$vacMongoViewPlus$ $vAR$